552595283	552595283	CD	B-NP	O
|	|	NN	I-NP	O
XNH	XNH	NN	I-NP	O
|	|	NN	I-NP	O
84531910	84531910	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
956011	956011	CD	B-NP	O
|	|	CC	I-NP	O
8/25/2002	8/25/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
chf	chf	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/19/2002	11/19/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/21/2002	5/21/2002	CD	B-NP	O
******	******	SYM	I-NP	B-cell_type
DISCHARGE	DISCHARGE	NN	I-NP	I-cell_type
ORDERS	ORDERS	NNS	I-NP	I-cell_type
******	******	SYM	B-NP	I-cell_type
BRODES	BRODES	NNPS	I-NP	O
,	,	,	O	O
ANTON	ANTON	NNP	B-NP	O
126-00-53-3	126-00-53-3	CD	I-NP	O
Quer	Quer	NNP	I-NP	O
Mil	Mil	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
8/7/02	8/7/02	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
Attending	Attend	VBG	B-VP	O
evaluation	evaluation	NN	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KE	KE	NN	B-NP	O
,	,	,	O	O
RANDOLPH	RANDOLPH	NN	B-NP	O
MONTY	MONTY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/26/02	2/26/02	CD	B-NP	O
by	by	IN	B-PP	O
RINELLA	RINELLA	NNP	B-NP	O
,	,	,	O	O
IVAN	IVAN	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
7.5	7.5	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
95874166	95874166	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
noted	note	VBN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/14/02	4/14/02	CD	B-NP	O
by	by	IN	B-PP	O
WASSEL	WASSEL	NNP	B-NP	O
,	,	,	O	O
MITCHEL	MITCHEL	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
93622526	93622526	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
noted	note	VBN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/14/02	4/14/02	CD	B-NP	O
by	by	IN	B-PP	O
DANCE	DANCE	NNP	B-NP	O
,	,	,	O	O
BRADLEY	BRADLEY	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
noted	note	VBN	B-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	B-protein
25	25	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	B-VP	O
50	50	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Take	Take	VB	B-VP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

COLACE	COLACE	NN	B-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
GLYBURIDE	GLYBURIDE	NNP	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
LISINOPRIL	LISINOPRIL	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
EVEN	EVEN	NNP	I-NP	O
days	day	NNS	I-NP	O
:	:	:	O	O
7.5	7.5	CD	B-NP	O
MG	MG	NN	I-NP	O
qd	qd	NN	I-NP	O
;	;	:	O	O
ODD	ODD	NN	B-NP	O
days	day	NNS	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
MG	MG	NN	I-NP	O
qd	qd	NN	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/18	10/18	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/26/02	2/26/02	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
noted	note	VBD	B-VP	O
Previous	Previous	NNP	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/14/02	4/14/02	CD	B-NP	O
by	by	IN	B-PP	O
BENETT	BENETT	NNP	B-NP	O
,	,	,	O	O
SHAUN	SHAUN	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
74762340	74762340	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
noted	note	VBN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/14/02	4/14/02	CD	B-NP	O
by	by	IN	B-PP	O
HEUMAN	HEUMAN	NNP	B-NP	O
,	,	,	O	O
BYRON	BYRON	NNP	B-NP	O
H.	H.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ASA	ASA	NN	B-NP	O
PO	PO	NN	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
05107759	05107759	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
noted	note	VBN	B-NP	O
ZOCOR	ZOCOR	NN	I-NP	B-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
20	20	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/26/02	2/26/02	CD	B-NP	O
by	by	IN	B-PP	O
MARGUARDT	MARGUARDT	NNP	B-NP	O
,	,	,	O	O
GARFIELD	GARFIELD	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
7.5	7.5	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
95874166	95874166	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
noted	note	VBN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/14/02	4/14/02	CD	B-NP	O
by	by	IN	B-PP	O
MARLIN	MARLIN	NNP	B-NP	O
,	,	,	O	O
MARTIN	MARTIN	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
noted	note	VBD	B-VP	O
NEXIUM	NEXIUM	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
METFORMIN	METFORMIN	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
RETURN	RETURN	NNP	I-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Yerty	Yerty	NNP	I-NP	O
1-2	1-2	NN	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Penicillins	Penicillin	NNS	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
chf	chf	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
chf	chf	NN	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
chronic	chronic	JJ	I-NP	O
Afib	Afib	NNP	I-NP	O
G-E	G-E	NN	I-NP	O
Reflux	Reflux	NN	I-NP	O
HTN	HTN	NN	I-NP	O
NIDDM	NIDDM	NN	I-NP	O
,	,	,	O	O
DIET	DIET	NN	B-NP	O
CTRL	CTRL	NN	I-NP	O
CHF	CHF	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
EF	EF	NN	I-NP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
colectomy	colectomy	NN	I-NP	O
for	for	IN	B-PP	O
diverticulitis	diverticulitis	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
S/P	S/P	NN	I-NP	O
colectomy	colectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
ventral	ventral	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
carpal	carpal	JJ	I-NP	O
tunnel	tunnel	NN	I-NP	O
release	release	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
carpal	carpal	JJ	I-NP	O
tunnel	tunnel	NN	I-NP	O
repair	repair	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ruq	ruq	NN	I-NP	O
u/s	u/	NNS	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
76yoF	76yoF	NN	B-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
afib	afib	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
rate	rate	NN	I-NP	O
controlled	control	VBN	B-VP	O
with	with	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
;	;	:	O	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
higher	high	JJR	B-NP	O
doses	dose	NNS	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
and	and	CC	I-NP	O
syncope	syncope	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
chf	chf	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ef	ef	NN	I-NP	O
50-55	50-55	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
8/01	8/01	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
p/w	p/w	NN	I-NP	I-protein
sob	sob	NN	I-NP	I-protein
x	x	SYM	B-VP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
dietary	dietary	JJ	B-NP	O
indiscretion	indiscretion	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
holidays	holiday	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
increased	increase	VBD	B-VP	O
salt	salt	NN	B-NP	B-protein
load	load	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
but	but	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
her	her	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
.	.	.	O	O

Reports	Report	NNS	B-NP	O
sob	sob	NN	I-NP	O
,	,	,	O	O
inc	inc	NN	B-NP	O
abd	abd	NN	I-NP	O
girth	girth	NN	I-NP	O
,	,	,	O	O
le	le	NN	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
pnd	pnd	NN	B-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
cough/fever	cough/fever	NN	I-NP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
:	:	:	O	O
rales	rale	NNS	B-NP	O
1/3	1/3	CD	B-NP	O
way	way	NN	I-NP	O
up	up	RB	B-ADVP	O
bilaterally	bilaterally	RB	I-ADVP	O
.	.	.	O	O

very	very	RB	B-NP	O
distended	distended	JJ	I-NP	O
abd	abd	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
+	+	SYM	I-NP	O
pitting	pit	VBG	I-NP	O
edema	edema	NN	I-NP	O
bilat	bilat	NN	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
slightly	slightly	RB	B-ADJP	O
wet	wet	JJ	I-ADJP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
Received	Receive	VBN	B-VP	O
80IV	80IV	CD	B-NP	O
lasix	lasix	CD	I-NP	O
in	in	IN	B-PP	O
ED	ED	VBN	B-VP	O
with	with	IN	B-PP	O
2L	2L	NN	B-NP	O
diuresis	diuresis	NN	I-NP	O
and	and	CC	I-NP	O
improvement	improvement	NN	I-NP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
PO	PO	NN	B-NP	O
lasix	lasix	CD	I-NP	O
then	then	RB	B-ADVP	O
switched	switch	VBD	B-VP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
meds	med	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
atenolol	atenolol	NN	I-NP	O
,	,	,	O	O
asa	asa	NN	B-NP	O
,	,	,	O	O
lisnopril	lisnopril	NN	B-NP	O
,	,	,	O	O
zocor	zocor	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

r/o	r/o	NN	B-NP	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
as	as	IN	B-PP	O
cause	cause	NN	B-NP	O
of	of	IN	B-PP	O
exacerbation	exacerbation	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
abd	abd	NN	B-NP	O
distension	distension	NN	I-NP	O
appears	appear	VBZ	B-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
proportion	proportion	NN	B-NP	O
to	to	TO	B-PP	O
right	right	JJ	B-NP	O
hear	hear	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
normal	normal	JJ	B-ADJP	O
but	but	CC	O	O
checking	check	VBG	B-VP	O
u/s	u/	NNS	B-NP	O
with	with	IN	B-PP	O
doppler	doppler	NN	B-NP	O
to	to	TO	B-VP	O
r/o	r/o	VB	I-VP	O
hepativ/portal	hepativ/portal	JJ	B-NP	O
venous	venous	JJ	I-NP	O
thrombus	thrombus	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
nexium	nexium	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
for	for	IN	B-PP	O
afib	afib	NN	B-NP	O
but	but	CC	B-PP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
gib	gib	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

endo	endo	LS	B-LST	O
:	:	:	O	O
dm	dm	NN	B-NP	O
.	.	.	O	O

on	on	IN	B-PP	O
metformin	metformin	NN	B-NP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
,	,	,	O	O
czi	czi	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
discharged	discharge	VBD	B-VP	O
on	on	IN	B-PP	O
4/4/01	4/4/01	CD	B-NP	O
after	after	IN	B-PP	O
an	an	DT	B-NP	O
adequate	adequate	JJ	I-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Difillippo	Difillippo	NNP	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
one	one	CD	I-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
adhere	adhere	VB	I-VP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
gm	gm	NN	I-NP	O
sodium	sodium	NN	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
fluid	fluid	NN	B-NP	O
restrict	restrict	VBP	B-VP	O
to	to	TO	B-PP	O
no	no	DT	B-NP	O
more	more	JJR	I-NP	O
than	than	IN	I-NP	O
8	8	CD	I-NP	O
glasses	glass	NNS	I-NP	O
of	of	IN	B-PP	O
liquid/water	liquid/water	NN	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
check	check	VB	I-VP	O
her	her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
call	call	NN	B-NP	O
PCP	PCP	NN	I-NP	O
if	if	IN	B-SBAR	O
weight	weight	NN	B-NP	O
increases	increase	VBZ	B-VP	O
by	by	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
three	three	CD	I-NP	O
pounds	pound	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
call	call	VB	I-VP	O
PCP	PCP	NN	B-NP	O
office	office	NN	I-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
a	a	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
one	one	CD	I-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
VNA	VNA	NN	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
pt	pt	NN	B-NP	O
to	to	TO	B-VP	O
measure	measure	VB	I-VP	O
weights	weight	NNS	B-NP	O
,	,	,	O	O
fill	fill	NN	B-NP	O
pill	pill	NN	I-NP	O
box	box	NN	I-NP	O
,	,	,	O	O
check	check	NN	B-NP	O
hr	hr	NN	I-NP	O
and	and	CC	O	O
bp	bp	NN	B-NP	O
and	and	CC	I-NP	O
check	check	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
taking	take	VBG	I-VP	O
lasix	lasix	CD	B-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
check	check	NN	I-NP	I-protein
in	in	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
with	with	IN	B-PP	O
results	result	NNS	B-NP	O
sent	send	VBN	B-VP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Merone	Merone	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
and	and	CC	O	O
qweek	qweek	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BORNMAN	BORNMAN	NNP	B-NP	O
,	,	,	O	O
ELDEN	ELDEN	NNP	B-NP	O
LAZARO	LAZARO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
RZ62	RZ62	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/7/02	8/7/02	CD	I-NP	O
@	@	HYPH	B-NP	O
12	12	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

